Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)Depreciation ExpenseEBIATGross ProfitLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

Vivos Therapeutics (VVOS) Receivables - Net (2019 - 2025)

Vivos Therapeutics has reported Receivables - Net over the past 7 years, most recently at $1.6 million for Q4 2025.

  • Quarterly Receivables - Net rose 267.67% to $1.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.6 million through Dec 2025, up 267.67% year-over-year, with the annual reading at $1.6 million for FY2025, 267.67% up from the prior year.
  • Receivables - Net was $1.6 million for Q4 2025 at Vivos Therapeutics, down from $2.1 million in the prior quarter.
  • Over five years, Receivables - Net peaked at $3.8 million in Q3 2021 and troughed at $202000.0 in Q4 2023.
  • The 5-year median for Receivables - Net is $754500.0 (2022), against an average of $1.1 million.
  • Year-over-year, Receivables - Net plummeted 77.41% in 2022 and then soared 370.04% in 2025.
  • A 5-year view of Receivables - Net shows it stood at $1.2 million in 2021, then tumbled by 62.01% to $457000.0 in 2022, then tumbled by 55.8% to $202000.0 in 2023, then surged by 112.87% to $430000.0 in 2024, then skyrocketed by 267.67% to $1.6 million in 2025.
  • Per Business Quant, the three most recent readings for VVOS's Receivables - Net are $1.6 million (Q4 2025), $2.1 million (Q3 2025), and $1.6 million (Q2 2025).